INTRODUCTION
============

A cervico-vaginal smear, including the conventional smear and liquid-based cytology, is a simple and inexpensive test for the prediction of squamous intraepithelial lesion (SIL) or squamous cell carcinoma (SqCC) of the uterine cervix.[@B1] These tests have contributed to a decrease in the incidence of cervical cancer, especially in geographic areas supported by well-organized screening programs.[@B1] Although several studies have reported on the diagnostic accuracy of the cervico-vaginal smear, results showed a wide range of estimated sensitivity compared to the specificity.[@B1][@B2][@B3][@B4][@B5][@B6][@B7][@B8][@B9][@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21][@B22][@B23][@B24][@B25][@B26][@B27][@B28][@B29][@B30][@B31][@B32][@B33][@B34][@B35][@B36][@B37][@B38] Because the diagnostic accuracy can be affected by variable factors, including study time, geographic area, and population,[@B1][@B2][@B3][@B4][@B5][@B6][@B7][@B8][@B9][@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21][@B22][@B23][@B24][@B25][@B26][@B27][@B28][@B29][@B30][@B31][@B32][@B33][@B34][@B35][@B36][@B37][@B38] it should be fully elucidated based on these standardized parameters, including the diagnostic grades of cytology. We tried to establish the universally acceptable value beyond the limitations of individual studies. A diagnostic test accuracy (DTA) review should be performed to confirm the cytology test outcomes of the uterine cervix.

To evaluate the diagnostic accuracy of cytology, the concordance rates between cytology and histology of the uterine cervix were investigated. In addition, the present study aimed to evaluate the diagnostic accuracy of cytology for SIL and SqCC of the uterine cervix through DTA review. A subgroup analysis based on the number of patients and study location was also conducted.

METHODS
=======

Published study search and selection criteria
---------------------------------------------

Relevant articles were obtained by searching the PubMed databases through January 31, 2018. There was no time limit for the start. These databases were searched using the following key words: '(Uterine Cervical Neoplasms OR Uterine Cervical Dysplasia OR Cervical Intraepithelial Neoplasia OR ((cervix OR cervical OR cervico\*) AND (cancer\* OR carcinoma OR adenocarcinoma OR neoplas\* OR dysplas\* OR dyskaryos\*)) OR (CIN OR CINII\* OR CIN2\* OR CINIII\* OR CIN3\*) AND (SIL OR HSIL OR H-SIL OR LSIL OR L-SIL OR ASCUS OR ASC-US).' The titles and the abstracts of all searched articles were screened for exclusion. Review articles, including the previous meta-analysis, were also screened to obtain additional eligible studies. Search results were then reviewed and articles were included if the study investigated the uterine cervix and there was information regarding the concordance between cytology and histology. The articles were excluded when they were case reports or non-original articles or non-English language publications.

Data extraction
---------------

Data from all eligible studies[@B1][@B2][@B3][@B4][@B5][@B6][@B7][@B8][@B9][@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21][@B22][@B23][@B24][@B25][@B26][@B27][@B28][@B29][@B30][@B31][@B32][@B33][@B34][@B35][@B36][@B37][@B38] were extracted by two independent authors. Extracted data included the following: first author\'s name, year of publication, study location, dates of the research, methodology of cytologic examination, and number of patients analyzed. For the meta-analysis, we extracted all data associated with the concordance between cytology and histology in various categories of comparison.

Statistical analyses
--------------------

The review of DTA was performed using the Meta-Disc program (version 1.4; Unit of Clinical Biostatics, the Ramon y Cajal Hospital, Madrid, Spain). In order to calculate the pooled sensitivity and specificity, individual data were collected from each eligible study in various categories of comparison. The summary receiver operating characteristic (SROC) curve was initially constructed by plotting 'sensitivity' and '1-specificity' of each study, and the curve fitting was performed through linear regression using the Littenberg and Moses linear model. Because the data were heterogeneous owing to differences in various methodology and populations, the accuracy data were pooled by fitting a SROC curve and measuring the value of the area under the curve (AUC). An AUC close to 1 indicates a strong test and an AUC close to 0.5 is considered as a poor test. In addition, the diagnostic odds ratio (OR) was calculated by the Meta-Disc program. The estimated values were those that predict abnormal histology of abnormal cytology. In addition, the estimated values of cytologic low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), and SqCC were predicted to histologic LSIL, HSIL or worse, and SqCC. To obtain the detailed information, a subgroup analysis based on number of patients, was conducted.

To obtain the results of concordance between abnormal cytology and histology, the Comprehensive Meta-Analysis software package was used (Biostat, Englewood, NJ, USA). The concordance was measured by agreement rates between HSIL identified with cytology and histology and between SqCC identified with cytology and histology. Because the eligible studies used various cytologic methods, including conventional and liquid-based preparations, in various populations, a random-effects model was more suitable than a fixed-effects model. Heterogeneity between the studies was checked using the Q and *I*^2^ statistics and presented using *P* values. To assess publication bias, Begg\'s funnel plot and Egger\'s test were used. The results were considered statistically significant at *P* \< 0.05.

RESULTS
=======

Selection and characteristics
-----------------------------

A total of 3,314 reports were searched and screened in the database. Due to insufficient information on concordance, 3,155 reports were excluded. An additional 48 reports were excluded owing to results reported on other diseases, 45 were excluded because they were non-original, and 28 articles were excluded because they were written in non-English language. Finally, 38 studies were included in the present analysis ([Fig. 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}), which provided data on 302,148 patients. Information on the concordance between abnormal cytology and histology test results is shown in [Table 1](#T1){ref-type="table"}.

![Flow chart of study search and selection methods.](jkms-34-e16-g001){#F1}

###### Main characteristics of the eligible studies

![](jkms-34-e16-i001)

  Study                            Location      Duration     Method   No.      No. of patients^a^                  
  -------------------------------- ------------- ------------ -------- -------- -------------------- -------- ----- --------
  Agorastos et al.[@B2]            Greece        2000--2001   CC       1,296    8                    14       8     22
  Agorastos et al.[@B3]            Greece        2011--2013   LBC      3,993    62                   18       63    45
  Alanbay et al.[@B4]              Turkey        2013--2015   CC       52       23                   17       9     0
  Beerman et al.[@B5]              Netherland    1997--2002   CC       86,469   347                  498      30    49,826
  Belinson et al.[@B6]             China         ND           LBC      8,497                                        
  Benedet et al.[@B7]              Canada        1986--2000   CC       84,244   44,847               15,561   628   1,163
  Bigras and de Marval[@B8]        Switzerland   ND           LBC      13,842   209                  150      285   884
  Blumenthal et al.[@B9]           Zimbabwe      1995--1997   CC       2,199                                        
  Canda et al.[@B10]               Turkey        2005         CC       5,835    6                    4        1     2
  2006--2009                       LBC                        13       4        2                    6              
  Cárdenas-Turanzas et al.[@B11]   USA/Canada    ND           CC       963      30                   47       104   782
  Castle et al.[@B12]              USA           2008--2009   LBC      7,823    482                  1,704    539   5,098
  Chung et al.[@B13]               Korea         2004         CC       1,221    27                   2        9     17
  LBC                                            32           2        3        17                                  
  Chute et al.[@B14]               USA           2003         CC       530      155                  133      11    231
  Cuzick et al.[@B15]              UK            1992--1994   CC       1,985    64                   54       43    43
  Cuzick et al.[@B16]              UK            ND           CC       10,358   117                  280      39    551
  Depuydt et al.[@B17]             Belgium       2005--2007   LBC      2,905    45                   27       42    153
  Ferreccio et al.[@B18]           Chile         ND           CC       8,265                                        
  Guo et al.[@B19]                 USA           2000--2001   LBC      788      551                  63       65    103
  Hovland et al.[@B20]             Congo         ND           CC       301                                          
  LBC                                                                                                               
  Hutchinson et al.[@B21]          Costa Rica    ND           CC       8,636    219                  357      101   7,956
  LBC                                            284          811      39       7,502                               
  Iftner et al.[@B22]              Germany       ND           LBC      9,451                                        
  Kim et al.[@B1]                  Korea         2005--2012   LBC      3,141    623                  152      47    2,319
  Li et al.[@B23]                  China         2004--2005   LBC      2,562                                        
  Mahmud et al.[@B24]              Congo         2003--2004   CC       1,366    16                   33       24    441
  McAdam et al.[@B25]              Vanuatu       2006         LBC      519      38                   13       13    6
  Monsonego et al.[@B26]           France        2008--2009   LBC      4,429    268                  117      344   378
  Negri et al.[@B27]               Italy         2000--2002   CC       214      27                   2        9     17
  LBC                                            36           5        1        3                                   
  Pan et al.[@B28]                 China         ND           LBC      1,780    174                  339      39    1,441
  Parakevaidis et al.[@B29]        Greece        1997--1999   CC       977      64                   179      11    34
  Petry et al.[@B30]               Germany       1998--2000   CC       8,466                                        
  Rahimi et al.[@B31]              Italy         ND           CC       461      16                   2        2     0
  LBC                                            14           3        4        1                                   
  Salmerón et al.[@B32]            Mexico        1999         CC       7,732    77                   59       72    213
  Sankaranarayanan et al.[@B33]    India         1999--2003   CC       24,915   718                  1,285    638   20,018
  Schneider et al.[@B34]           Germany       1996--1998   CC       5,455    24                   2        140   193
  Sigurdsson[@B35]                 Iceland       2007--2011   CC       61,574   1,603                206      24    18
  LBC                                            1,081        111      7        57                                  
  Sykes et al.[@B36]               New Zealand   2004--2006   CC       913      250                  60       16    35
  LBC                                            253          59       23       41                                  
  Wu et al.[@B37]                  China         ND           LBC      2,098                                        
  Zhu et al.[@B38]                 Sweden        ND           CC       137      84                   25       23    5
  LBC                                            89           23       18       7                                   

TP = true positive, FP = false positive, FN = false negative, TN = true negative, CC = conventional cytology, LBC = liquid-based cytology, ND = no description.

^a^Concordance between abnormal cytology and abnormal histology.

DTA review of cytology
----------------------

A DTA review was conducted to elucidate the diagnostic accuracy using cytology in uterine cervix. In the comparison between abnormal cytology and histology, the pooled sensitivity and specificity values were 93.9% (95% confidence interval \[CI\], 93.7%--94.1%) and 77.6% (95% CI, 77.4%--77.8%), respectively ([Fig. 2](#F2){ref-type="fig"}). The diagnostic OR and AUC on the SROC curve were 8.90 (95% CI, 5.57--14.23) and 0.8112, respectively ([Fig. 3](#F3){ref-type="fig"}). A subgroup analysis based on the number of included patients of each eligible study (≥ 1,000 and \< 1,000) and study locations (areas with well-organized versus insufficient screening programs) was conducted. In the subgroup that included the larger number of patients, the pooled sensitivity and specificity, diagnostic OR and AUC on the SROC curve were 94.9% (95% CI, 94.8%--95.1%), 77.8% (95% CI, 77.5%--78.0%), 22.91 (95% CI, 10.70--49.04), and 0.8963, respectively. However, the pooled sensitivity and specificity of the subgroup with a smaller number of patients was 71.1% (95% CI, 69.3%--72.9%) and 73.6% (95% CI, 72.2%--75.0%), respectively. Next, in the subgroup analysis based on study location, areas with well-organized screening programs had a higher sensitivity than areas with insufficient screening programs (94.9% vs. 71.1%).

![The forest plots for the sensitivity and specificity of abnormal cytology in predicting SIL or SqCC in uterine cervix. (**A**) Sensitivity. (**B**) Specificity.\
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![SROC curve of abnormal cytology in predicting SIL or SqCC in uterine cervix.\
SROC = summary receiver operating characteristic, SIL = squamous intraepithelial lesion, SqCC = squamous cell carcinoma, AUC = area under the curve, SE = standard error, Q\* = the point where sensitivity and specificity are equal.](jkms-34-e16-g003){#F3}

In the comparison between LSIL identified with cytology and LSIL identified with histology, the pooled sensitivity and specificity, diagnostic OR, and AUC were 80.5% (95% CI, 78.7%--81.2%), 80.6% (95% CI, 80.2%--81.0%), 11.80 (95% CI, 5.30--26.29), and 0.8339, respectively ([Table 2](#T2){ref-type="table"}). For predicting HSIL or worse histology, the sensitivity and specificity of LSIL cytology were 97.6% (95% CI, 97.4%--97.8%) and 71.7% (95% CI, 71.3%--72.0%), respectively. The diagnostic OR and AUC were 64.49 (95% CI, 29.04--143.20) and 0.9444, respectively. The pooled sensitivity and specificity, diagnostic OR, and AUC of cytologic SqCC were 92.7% (95% CI, 87.3%--96.3%), 87.5% (95% CI, 87.2%--87.8%), 865.81 (95% CI, 68.61--10,925.12), and 0.9855 for predicting SqCC in histology. In the subgroup analysis, those that used conventional cytology and well-organized screening programs had a higher sensitivity and lower specificity than subgroups that used liquid-based cytology and lacked screening programs.

###### Sensitivity, specificity, diagnostic OR and AUC of SROC curve in cases with histologic confirmation

![](jkms-34-e16-i002)

  Comparison                                Sensitivity, % (95% CI)   Specificity, % (95% CI)   Diagnostic OR (95% CI)      AUC on SROC
  ----------------------------------------- ------------------------- ------------------------- --------------------------- -------------
  LSIL in cytology vs. LSIL in histology    80.5 (78.7--81.2)         80.6 (80.2--81.0)         11.80 (5.30--26.29)         0.8339
  HSIL in cytology vs. HSIL+ in histology   97.6 (97.4--97.8)         71.7 (71.3--72.0)         64.49 (29.04--143.20)       0.9444
  SqCC in cytology vs. SqCC in histology    92.7 (87.3--96.3)         87.5 (87.2--87.8)         865.81 (68.61--10,925.12)   0.9855

OR = odds ratio, AUC = area under curve, SROC = summary receiver operating characteristic, CI = confidence interval, LSIL = low-grade squamous intraepithelial lesion, HSIL = high-grade squamous intraepithelial lesion, HSIL+ = HSIL or worse, SqCC = squamous cell carcinoma.

DISCUSSION
==========

In daily practice, screening tests use cytology and/or the human papillomavirus (HPV) test to predict SIL and SqCC of the uterine cervix. However, it is difficult to obtain information on diagnostic accuracy of cytology and the HPV test from individual studies. Previous studies show that the ranges of sensitivities and specificities of cytology and HPV test varied widely.[@B39] In the eligible studies, sensitivities and specificities of cytology ranged from 22.4% to 99.4% and 0.0% to 99.0%, respectively.[@B1][@B2][@B3][@B4][@B5][@B6][@B7][@B8][@B9][@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21][@B22][@B23][@B24][@B25][@B26][@B27][@B28][@B29][@B30][@B31][@B32][@B33][@B34][@B35][@B36][@B37][@B38] Therefore, it is useful to assess the diagnostic accuracy of a screening test to predict the presence of SIL and SqCC in the uterine cervix by performing a meta-analysis, including a DTA review. To the best of our knowledge, the present study is the first to assess the diagnostic accuracy of cytology for predicting SIL and SqCC in the uterine cervix.

In the present DTA review, regardless of the diagnostic grade of cytology, its diagnostic accuracy was initially evaluated for the prediction of abnormal histology. The sensitivity and specificity of cytology were 93.9% and 77.6%, respectively. In a subgroup analysis based on the number of patients, the larger subgroup showed a higher sensitivity than the smaller subgroup (94.9% vs. 71.1%). Eligible studies with a small number of patients might affect the sensitivity and specificity, since patient cohort sizes ranged from 13 to 50,701. In addition, experiences of cytopathologists and cytotechnologists may be important for the diagnostic accuracy of cytologic examination. Recent automated cytoscreening systems can also be helpful for effective screening. Results of this DTA review show that cytology is a useful screening test in the prediction of SIL or SqCC histology.

In the DTA review for the diagnostic accuracy of cytology, index should be cytology and comparator test should be histology. However, in previous studies, colposcopy was included in the comparator test.[@B39] Cases with negative colposcopic findings were considered as true negative in these studies.[@B39] However, because colposcopy is not a confirmative examination, specificity might be overestimated due to the increase in true negative cases. Therefore, cytology and histology should be compared to properly evaluate the diagnostic accuracy. The present study included only patients with histologic confirmation, but not those who underwent colposcopic examination.

In a previous DTA review, the sensitivity of cytology and HPV test were 65.87%--75.51% and 92.60%--95.13%, respectively.[@B39] However, in this study, cytology was compared between atypical squamous cells of undetermined significance (ASC-US) or worse cytology and HSIL histology. The true positive rate and sensitivity were decreased because patients who underwent LSIL histology were considered false positives in abnormal cytology. The sensitivity of cytology was higher in our study compared to the previous DTA review. Therefore, overestimation of specificity could be possibly considered. In addition, the previous DTA review only included studies that assessed both cytology and HPV tests. The estimated value for diagnostic OR and AUC on SROC, which are useful in comparing various tests, were not shown. In summary, the superiority of the HPV test for accurately diagnosing SIL or SqCC in the uterine cervix cannot be proven in the previous DTA review. In addition, in other DTA review,[@B40] the pooled sensitivity of cytology with HSIL or worse was 79.4% for predicting cancer. However, this review did not show results for other parameters, such as specificity, diagnostic OR, AUC on SROC. The estimated values of overall abnormal cytology and LSIL were not found in the previous review.[@B40]

In practice, ASC-US cytology usually requires a repeat smear and/or an HPV test. An ancillary test, such as the HPV test, may be useful because the confirmative information in the repeat smear cannot be obtained. However, the gradient correlation between HPV test and histology is unclear. The advantage of cytology is its ability to predict histologic abnormalities which can help with patient management, compared to that of an HPV test. After a cytologic preparation, HPV tests using the remaining cytologic specimen can be performed. The presence of ASC-US cytology groups, which can increase the false-positive rate and decrease sensitivity. In the previous study, the rate of ASC-US cytology was less than 5.0%.[@B12] However, in the Republic of Korea which has a well-organized screening system, the rate of ASC-US were 0.045% in 432,691 women who had screening tests.[@B1] Therefore, an ancillary HPV test can be more useful in patients with ASC-US cytology. In areas with insufficient screening systems, the effectiveness of a cytologic examination is not fully elucidated. In addition, in areas with a well-organized screening system, the usefulness of an HPV test as the primary screening test is unclear. Primary screening tests should not be selected by simply considering the sensitivity. Availability of screening systems may be important for choosing the screening method to help diagnose SIL or SqCC of the uterine cervix.

In a subanalysis of the ATHENA study, co-testing using cytology and the HPV test has no advantage compared with the HPV test alone.[@B12] However, this study did not enroll patients without an HPV test. This criterion could decrease the sensitivity and true positive cases of cytology. In addition, this report compared ASC-US and worse cytology with HSIL or worse confirmed with histology. Therefore, because sensitivity can differ by patient populations, the diagnostic accuracy of the screening test in the general population can differ between individual studies. The results showed that sensitivity of cytology in our results (96.9%) was higher than that of the HPV test sensitivity for HSIL or worse with histology as shown in Castle\'s report (88.2%). In addition, in our study, the estimated concordance rates were 93.1% (95% CI, 84.7%--97.1%) and 98.8% (95% CI, 69.0%--100.0%) for HSIL and SqCC cytology, respectively.

There are some limitations in the current DTA review. First, the comparisons between various cytologic abnormalities and histologic abnormalities were conducted in the present DTA review. ASC-US/atypical squamous cells, cannot exclude HSIL (ASC-H) cytology belongs to the heterogeneous diagnostic category. However, the diagnostic accuracy of ASC-H could not be performed due to insufficient information included in the eligible studies. Second, the aim of the present DTA review was to elucidate the diagnostic accuracy of cytology. Thus, the effectiveness between cytology and HPV test was compared with the results of previous reports.[@B12][@B39] Third, the number of patients in the individual studies did not apply to exclusion criteria in the present DTA review. The eligible studies with a smaller number of patients showed far from average estimation. However, the effects of studies with a smaller number of patients on overall estimated values were insignificant. Therefore, the diagnostic accuracy of cytology using individual studies with a smaller number of patients should be accurately interpreted. Fourth, histologic examinations include a punch biopsy, loop electrocautery excision procedure, conization, or hysterectomy in the uterine cervix. Sampling error can occur with histologic examinations, such as a punch biopsy. However, in the present DTA review, a detailed evaluation based on histologic methodology could not be conducted due to insufficient information on eligible studies.

In conclusion, our results show that cytology has higher sensitivity and specificity for the prediction of SIL or SqCC, regardless of the diagnostic grade of cytology. The diagnostic accuracy of cytology as a primary screening test was re-confirmed in the present DTA review. Therefore, cytology is one of the most sensitive and confirmative primary screening tests for SIL and SqCC.
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